Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.
Preusser, P, Wilke, H, Achterrath, W, Fink, U, Lenaz, L, Heinicke, A, Meyer, J, Meyer, H J, Buente, HVolume:
7
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1989.7.9.1310
Date:
September, 1989
File:
PDF, 628 KB
english, 1989